Functional Activity of Enantiomeric Oximes and Diastereomeric Amines and Cyano Substituents at C9 in 3-Hydroxy-N-phenethyl-5-phenylmorphans
Molecules · 2024
DOI: 10.3390/molecules29091926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Hudson G Roth und 8 weiteren Autor:innen. Beteiligte Einrichtung: Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse …. Hauptthemen laut MEDLINE: Oximes, Amines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, DA051377, Kentucky Medical Services Foundation Endowed Chair in Pharmacy.
Abstract (Originalsprache)
The synthesis of stereochemically pure oximes, amines, saturated and unsaturated cyanomethyl compounds, and methylaminomethyl compounds at the C9 position in 3-hydroxy-N-phenethyl-5-phenylmorphans provided μ-opioid receptor (MOR) agonists with varied efficacy and potency. One of the most interesting compounds, (2-((1S,5R,9R)-5-(3-hydroxyphenyl)-2-phenethyl-2-azabicyclo[3.3.1]nonan-9-yl)acetonitrile), was found to be a potent partial MOR agonist (EC50 = 2.5 nM, %Emax = 89.6%), as determined in the forskolin-induced cAMP accumulation assay. Others ranged in potency and efficacy at the MOR, from nanomolar potency with a C9 cyanomethyl compound (EC50 = 0.85 nM) to its totally inactive diastereomer, and three compounds exhibited weak MOR antagonist activity (the primary amine 3, the secondary amine 8, and the cyanomethyl compound 41). Many of the compounds were fully efficacious; their efficacy and potency were affected by both the stereochemistry of the molecule and the specific C9 substituent. Most of the MOR agonists were selective in their receptor interactions, and only a few had δ-opioid receptor (DOR) or κ-opioid receptor (KOR) agonist activity. Only one compound, a C9-methylaminomethyl-substituted phenylmorphan, was moderately potent and fully efficacious as a KOR agonist (KOR EC50 = 18 nM (% Emax = 103%)).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National I…
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA.
- Center for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC 20375-0001, USA.
ORCID-Profile: Madhurima Das, Agnieszka Sulima, Dan Luo, Thomas E Prisinzano, Arthur E Jacobson, Kenner C Rice
Förderung
- NIDA NIH HHS
- DA051377
- Kentucky Medical Services Foundation Endowed Chair in Pharmacy
Zitieren
APA
Roth, H. G., Das, M., Sulima, A., Luo, D., Kaska, S., Prisinzano, T. E., Kerr, A. T., Jacobson, A. E., & Rice, K. C. (2024). Functional Activity of Enantiomeric Oximes and Diastereomeric Amines and Cyano Substituents at C9 in 3-Hydroxy-N-phenethyl-5-phenylmorphans. Molecules. https://doi.org/10.3390/molecules29091926
Vancouver
Roth HG, Das M, Sulima A, Luo D, Kaska S, Prisinzano TE, et al. Functional Activity of Enantiomeric Oximes and Diastereomeric Amines and Cyano Substituents at C9 in 3-Hydroxy-N-phenethyl-5-phenylmorphans. Molecules. 2024. doi:10.3390/molecules29091926
BibTeX
@article{Roth2024,
author = {Roth, Hudson G and Das, Madhurima and Sulima, Agnieszka and Luo, Dan and Kaska, Sophia and Prisinzano, Thomas E and Kerr, Andrew T and Jacobson, Arthur E and Rice, Kenner C},
title = {Functional Activity of Enantiomeric Oximes and Diastereomeric Amines and Cyano Substituents at C9 in 3-Hydroxy-N-phenethyl-5-phenylmorphans},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29091926}
}
EUVIMED